| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Approval and Withdrawal of New Antibiotics and other Antiinfectives in the U.S., 1980–2009
|
Outterson, Kevin
|
|
2013
|
41 |
3 |
p. 688-696
|
artikel
|
| 2 |
Calendar of Events
|
|
|
2013
|
41 |
3 |
p. 746
|
artikel
|
| 3 |
Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health
|
Gagnon, Marc-André
|
|
2013
|
41 |
3 |
p. 571-580
|
artikel
|
| 4 |
Curbing Misconduct in the Pharmaceutical Industry: Insights from Behavioral Ethics and the Behavioral Approach to Law
|
Feldman, Yuval
|
|
2013
|
41 |
3 |
p. 620-628
|
artikel
|
| 5 |
Drug Firms, the Codification of Diagnostic Categories, and Bias in Clinical Guidelines
|
Cosgrove, Lisa
|
|
2013
|
41 |
3 |
p. 644-653
|
artikel
|
| 6 |
Epigenetic Exceptionalism
|
Rothstein, Mark A.
|
|
2013
|
41 |
3 |
p. 733-736
|
artikel
|
| 7 |
Ethical Quandaries in Gamete-Embryo Cryopreservation Related to Oncofertility
|
Ayensu-Coker, Leslie
|
|
2013
|
41 |
3 |
p. 711-719
|
artikel
|
| 8 |
Five Un-Easy Pieces of Pharmaceutical Policy Reform
|
Rodwin, Marc A.
|
|
2013
|
41 |
3 |
p. 581-589
|
artikel
|
| 9 |
From Bad Pharma to Good Pharma: Aligning Market Forces with Good and Trustworthy Practices through Accreditation, Certification, and Rating
|
Miller, Jennifer E.
|
|
2013
|
41 |
3 |
p. 601-610
|
artikel
|
| 10 |
From Community to Commodity: The Ethics of Pharma-Funded Social Networking Sites for Physicians
|
Landa, Amy Snow
|
|
2013
|
41 |
3 |
p. 673-679
|
artikel
|
| 11 |
Institutional Corruption and the Pharmaceutical Policy
|
Rodwin, Marc A.
|
|
2013
|
41 |
3 |
p. 544-552
|
artikel
|
| 12 |
“Institutional Corruption” Defined
|
Lessig, Lawrence
|
|
2013
|
41 |
3 |
p. 553-555
|
artikel
|
| 13 |
Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs
|
Light, Donald W.
|
|
2013
|
41 |
3 |
p. 590-600
|
artikel
|
| 14 |
Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won't Cast Light on
|
Sismondo, Sergio
|
|
2013
|
41 |
3 |
p. 635-643
|
artikel
|
| 15 |
Major Trends in Public Health Law and Practice: A Network National Report
|
Hodge, James G.
|
|
2013
|
41 |
3 |
p. 737-745
|
artikel
|
| 16 |
Parallel Problems: Applying Institutional Corruption Analysis of Congress to Big Pharma
|
Fields, Gregg
|
|
2013
|
41 |
3 |
p. 556-560
|
artikel
|
| 17 |
Patient Advocacy Organizations: Institutional Conflicts of Interest, Trust, and Trustworthiness
|
Rose, Susannah L.
|
|
2013
|
41 |
3 |
p. 680-687
|
artikel
|
| 18 |
Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda
|
Jorgensen, Paul D.
|
|
2013
|
41 |
3 |
p. 561-570
|
artikel
|
| 19 |
Physicians under the Influence: Social Psychology and Industry Marketing Strategies
|
Sah, Sunita
|
|
2013
|
41 |
3 |
p. 665-672
|
artikel
|
| 20 |
Producing Knowledge about Racial Differences: Tracing Scientists' Use of “Race” and “Ethnicity” from Grants to Articles
|
Friedman, Asia
|
|
2013
|
41 |
3 |
p. 720-732
|
artikel
|
| 21 |
Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use
|
Rodwin, Marc A.
|
|
2013
|
41 |
3 |
p. 654-664
|
artikel
|
| 22 |
“Something of an Adventure”: Postwar NIH Research Ethos and the Guatemala STD Experiments
|
Spector-Bagdady, Kayte
|
|
2013
|
41 |
3 |
p. 697-710
|
artikel
|
| 23 |
The Ethics of Pharmaceutical Research Funding: A Social Organization Approach
|
Gray, Garry C.
|
|
2013
|
41 |
3 |
p. 629-634
|
artikel
|
| 24 |
Understanding Pharmaceutical Research Manipulation in the Context of Accounting Manipulation
|
Brown, Abigail
|
|
2013
|
41 |
3 |
p. 611-619
|
artikel
|
Tijdschrift beschrijving